Quick Answer
Adagio Medical Holdings, Inc. reported Cash and Equivalents of $17.11 million for fiscal year 2025.
Adagio Medical Holdings, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $17.11M | -16.9% |
| 2024 | $20.59M | +1388.5% |
| 2023 | $1.38M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.67M | -83.5% | -43.0% |
| June 30, 2025 | $8.20M | — | -36.7% |
| March 31, 2025 | $12.96M | — | -37.0% |
| December 31, 2024 | $20.59M | +1388.5% | -27.2% |
| September 30, 2024 | $28.26M | — | +1943.4% |
| December 31, 2023 | $1.38M | — | — |
- Adagio Medical Holdings, Inc. showed a decrease of -16.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Adagio Medical Holdings, Inc.’s cash and equivalents has grown by 1136.8% (from $1.38 million to $17.11 million).
- The most recent figure is from Adagio Medical Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: